Axcella Health (NASDAQ: AXLA)
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-11-09 | ||||||
REV |
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-23 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Axcella Health (NASDAQ: AXLA) through any online brokerage.
Other companies in Axcella Health’s space includes: Fortress Biotech (NASDAQ:FBIO), Anixa Biosciences (NASDAQ:ANIX), CytomX Therapeutics (NASDAQ:CTMX), Galectin Therapeutics (NASDAQ:GALT) and OncoCyte (NASDAQ:OCX).
The latest price target for Axcella Health (NASDAQ: AXLA) was reported by HC Wainwright & Co. on Wednesday, August 3, 2022. The analyst firm set a price target for 8.00 expecting AXLA to rise to within 12 months (a possible 253.98% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Axcella Health (NASDAQ: AXLA) is $2.26 last updated August 9, 2022, 8:00 PM UTC.
There are no upcoming dividends for Axcella Health.
Axcella Health’s Q3 earnings are confirmed for Wednesday, November 9, 2022.
There is no upcoming split for Axcella Health.
Axcella Health is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.